ÂÜÀòÂÒÂ×

Greg Scanlon is the VP of Pipeline Lead for Sterile Injectables at Pfizer, where they lead a dynamic team focused on advancing the Hospital Business through both organic and inorganic development activities. They have held various leadership roles at Pfizer, including overseeing commercial strategy and business transformation, and are known for effectively turning strategy into actionable results. Prior to joining Pfizer, Greg gained experience in strategy and operations management consulting at Deloitte. They hold a first-class honors degree in Medicinal Chemistry from Trinity College Dublin, which involved research at Harvard Medical School and the University of Regensburg. Greg is also a Chartered Management Accountant and was a recognized national prizewinner during their professional studies.